Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...

Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, ...

Nausea is the most common tirzepatide side effect. In Zepbound clinical trials, 25 to 28 percent of people reported nausea. Tirzepatide might cause nausea because it ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

The retrospective study could not determine whether some patients were more likely than others to keep off the weight.

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two ...

Weight loss drugs like Ozempic and Wegovy have had a meteoric rise in recent years, but how fast does the weight return after ...

Comprehensive Analysis of Tirzepatide Access Options as Resolution Season Peaks: MyStart Health Programs, FDA Context, Coverage Developments, and Questions to Consider Before Starting GLP-1 ...